Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 4
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2016 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study.
de Veer RC, van Hooff MCB, Werner E, Beuers U, Drenth JPH, Cuperus FJC, van Hoek B, Veldt BJ, Klemt-Kropp M, van Meer S, Verdonk RC, Flink HJ, Vrolijk JM, Gevers TJG, Ponsioen CY, Ter Borg MJ, Soufidi K, Boersma F, de Jonge HJM, Wolfhagen FHJ, Baak LC, Onderwater SL, van Bergeijk JD, van Putten PG, de Bruin GJ, Adang RPR, Aparicio-Pages MN, de Boer W, Borg FT, van Soest H, Janssen HLA, Hansen BE, Erler NS, van der Meer AJ; Dutch PBC Study Group. de Veer RC, et al. Among authors: flink hj. JHEP Rep. 2024 Jun 6;6(8):101132. doi: 10.1016/j.jhepr.2024.101132. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39113899 Free PMC article.
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL. Buster EH, et al. Among authors: flink hj. Gastroenterology. 2008 Aug;135(2):459-67. doi: 10.1053/j.gastro.2008.05.031. Epub 2008 May 15. Gastroenterology. 2008. PMID: 18585385 Clinical Trial.
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Hansen BE, Schalm SW, Janssen HL; HBV 99-01 Study Group. van Zonneveld M, et al. Among authors: flink hj. Aliment Pharmacol Ther. 2005 May 1;21(9):1163-71. doi: 10.1111/j.1365-2036.2005.02453.x. Aliment Pharmacol Ther. 2005. PMID: 15854180 Free article. Clinical Trial.
14 results